Nanotechnology Now - Press Release: RNAi Asia / Screening Asia 2010

Home > Press > RNAi Asia / Screening Asia 2010

Abstract:
15th-16th November 2010, Singapore

RNAi Asia / Screening Asia 2010

Singapore | Posted on August 18th, 2010

Select Biosciences is proud to announce their inaugural RNAi/Screening Asia Conference. This year's event will take place at the Matrix Building, Biopolis in Singapore.

Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organizing a two day event, gathering some of the most influential players in the field from Asia and across the globe.

The agenda will include world leading research from renowned speakers including:

RNAi Asia

· John Mattick
Professor, University of Queensland

· Alan Sachs
Vice President, RNA Therapeutics, Merck Research Laboratories

· Dan Peer
Head, Laboratory of Nanomedicine, Tel Aviv University

· Shih-Peng Chan
Assistant Professor, National Taiwan University

Screening Asia

· Rathnam Chaguturu
Director, High Throughput Screening Laboratories, University of Kansas

· Paul Orange
Business Leader, Bio-Discovery, Perkin Elmer

· Hakim Djaballah
Director, Sloan-Kettering

· Sitta Sittampalam
Professor, University of Kansas

... and many more!

The full two day agenda includes the following sessions in RNAi Asia:

· Target Discovery and Validation
· Transfection
· siRNA Therapeutics
· in vivo RNAi
· siRNA library screens
· microRNAs

And in Screening Asia:

· High Content Screening
· Assay Development and Analysis
· Novel Screening Platforms and Technologies
· Screening and Drug Discovery
· Biosimilars & Biologics
· Natural Products Screening

To guarantee a high attendance at this exciting event Select Biosciences will maintain their traditional low registration fees and group booking discounts.

Full conference passes include admission to all sessions and the exhibition as well as conference documentation.

Lunch, coffee breaks and the drinks reception provide ample time for networking and to continue discussions from the question and answer sessions.

The conferences division of Select Biosciences Ltd. is focused on organizing specialist biomedical meetings each year. Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.

For further information contact Kirit Shah,